J&J seeks in excess of $5 billion in damages and interest from Boston Scientific, a potentially massive judgment against a company that as of Tuesday had a market capitalisation of $17.8 billion

Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback (...)

Sales forecasts for Novartis’s new heart failure drug are being ramped up by analysts after good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease.

Sales forecasts for Novartis’s new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doct(...)

Credit Agricole saw its profit almost wiped out in the second quarter as a result of its holding in  troubled Portuguese lender Banco Espirito Santo. Photograph: Hugo Correia/Reuters

Credit Agricole, France’s third- largest bank by market value, said profit was almost wiped out in the second quarter on charges tied to its stake in (...)

A sign of US bank Goldman Sachs on the floor of the New York Stock Exchange. EPA/JUSTIN LANE

Wall Street firms led by Goldman Sachs Group are close to buying a stake in chat and instant messaging startup Perzo in pursuit of an alternative to a(...)

Blister packs of over-the-counter allergy medicines, manufactured by Perrigo. Perrigo agreed to buy Irish drug company Elan for $8.6 billion in 2013, thereby gaining a low-tax base for international expansion. Now it is being cited as a potential acquisition target for larger companies looking to pursue a similar strategy. Photograph: Andrew Harrer/Bloomberg

Dublin based drugmaker Perrigo may join Swiss based Actelion and UK-based medical device company Smith and Nephew as acquisition targets for US healt(...)

Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire . Photographer: JB Reed/Bloomberg News

Shire, which has spurned a $46 billion takeover offer from US group AbbVie as inadequate, has a new reason to argue it is worth more after a US court (...)

Richard Pops, Alkermes chief executive, says that the company is not interested in being bought out as it nears the launch of new drugs.Photograph: Dara Mac Dónaill / THE IRISH TIMES

Dublin-based Alkermes has the low-tax domicile currently in vogue among multinational pharmaceutical companies but is not interested in being bought o(...)

Lloyds was ordered to sell the 631 TSB branches by European regulators by the end of 2015 as a condition of its state  bailout. Photograph: Matthew Lloyd/Bloomberg

Shares in TSB rose sharply following its debut on the London stock market after Lloyds Banking Group sold more of the offshoot business than originall(...)

Fatface has pulled its planned London listing, raising fears a window for flotations may be closing.

Clothing chain Fat Face is pulling the plug on its planned £110 million listing in London, citing poor equity market conditions, and adding to signs(...)

Wm Morrison Supermarkets, which has been losing market share to discounters Aldi and Lidl and lagged rivals in entering fast-growing online and convenience store markets, said its profits would more than halve this year

Britain’s Wm Morrison Supermarkets sparked talk of an industry price war today after it posted its lowest profit for five years and said it wou(...)